Skip to main content

PharmacoEconomics

Ausgabe 11/2007

Inhalt (7 Artikel)

Editorial

Warfarin Pharmacogenetics

Dyfrig A. Hughes, Munir Pirmohamed

Leading Article

It’s Time to Choose the Study Design!

Oren Shavit, Moshe Leshno, Assaf Goldberger, Amir Shmueli, Amnon Hoffman

Review Article

The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis

Rachael L. Fleurence, Cynthia P. Iglesias, Jeanene M. Johnson

Review Article

Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation

Alec H. Miners, Guiqing Yao, James Raftery, Rod S. Taylor

Original Research Article

Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia

Amanda R. Patrick, Wolfgang C. Winkelmayer, Jerry Avorn, Michael A. Fischer

Original Research Article

Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B

David L. Veenstra, Sean D. Sullivan, Lauren Clarke, Uche H. Iloeje, Eskinder Tafesse, Adrian Di Bisceglie, Kris V. Kowdley, Robert G. Gish

Original Research Article

The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary

M’arcio Machado, Michael Iskedjian, In’es A. Ruiz, Thomas R. Einarson